Skip to main content
MEMPHASYS LIMITED. logo

MEMPHASYS LIMITED. — Investor Relations & Filings

Ticker · MEM ISIN · AU000000MEM5 LEI · 549300RZ3LBXHF3WXL97 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2008-02-19 Director's Dealing
Country AU Australia
Listing ASX MEM

About MEMPHASYS LIMITED.

https://www.memphasys.com/

Memphasys Limited is a biotechnology company specializing in the development of advanced cell separation and reproductive biotechnology solutions. The company's core technology platform utilizes proprietary membranes and electrophoresis to isolate high-quality cells from biological fluids. Its flagship product, the Felix™ system, is an automated device designed for the rapid separation of high-quality sperm from semen samples for use in human assisted reproductive technology (ART) procedures. This technology aims to improve clinical outcomes by selecting sperm with lower DNA fragmentation and higher motility compared to traditional centrifuge-based techniques. Beyond human fertility, the company applies its bio-separation expertise to animal health, including diagnostic tools for stallion fertility. Memphasys focuses on providing innovative solutions that enhance efficiency and success rates in the global reproductive health market.

Recent filings

Filing Released Lang Actions
Appendix 3Y and Completion of Share buyback 6 pages ?Kb
Director's Dealing Classification · 100% confidence The document is an announcement titled 'Appendix 3Y and Completion of share buyback under the Unmarketable Parcel Sale Facility'. It details the completion of a share buyback program and includes multiple 'Appendix 3Y' forms, which are notices of changes in directors' interests in securities. The content focuses on directors acquiring shares under the buyback facility and discloses their shareholdings before and after the transactions. The document is regulatory in nature, reporting insider transactions by directors as required by listing rules and the Corporations Act. It does not contain financial statements, earnings data, or management discussion of financial results. It is not a full report but a regulatory announcement of directors' dealings in shares. Therefore, the appropriate classification is 'Director's Dealing' (DIRS). The document length (8471 characters) supports it being a detailed regulatory announcement rather than a brief notice or a full financial report.
2008-02-19 English
NuSep Half Year Report 17 pages ?Kb
Regulatory Filings
2008-02-11 English
NuSep Forecast Financials to June 2008 5 pages ?Kb
Interim / Quarterly Report Classification · 95% confidence The document is a press release dated 12 February 2008 from NuSep Ltd providing an update on current trading and anticipated financial results to 30 June 2008. It includes retrospective results for the six months ended 31 December 2007 and forecasts for the full fiscal year ending 30 June 2008. The document discusses sales growth, product launches, production capacity, management discussion of financial performance including losses and revenue, and forward-looking statements. It is not a full annual report or interim report with detailed financial statements, but rather a financial update and outlook. The document is longer than 5,000 characters and contains substantive financial data and management discussion, which aligns with an Interim / Quarterly Report (IR) classification rather than a simple earnings release or regulatory announcement. Therefore, the most appropriate classification is Interim / Quarterly Report (IR).
2008-02-11 English
NuSep Appendix 3X 10 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and repeatedly references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the securities holdings and interests of various directors, including fully paid ordinary shares, listed and unlisted share options, and notes on vesting schedules. The document is a formal notification of directors' personal share transactions and interests in the company securities. There is no financial performance data, earnings information, or management discussion. The content aligns with reporting of insider share transactions by directors. According to the filing definitions, this corresponds to 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length and detail confirm it is the actual notice, not a brief announcement or certification. Therefore, the correct classification is DIRS (Director's Dealing).
2008-01-22 English
NuSep Appendix 3Y Increase in Director Shareholdering 4 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Increase in Director’s Shareholding' and details the acquisition of shares by Mr. John Manusu, the Managing Director of NuSep Ltd. It includes specific information about the number of shares acquired, dates, and the nature of the transactions. The document references ASX Listing Rule 3.19A.2 and the Corporations Act section 205G, which pertain to disclosures of directors' interests in securities. The content is focused on reporting a director's personal share transactions rather than financial results, management changes, or other corporate events. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is sufficient and contains detailed transaction data, confirming it is not a mere announcement or certification. Therefore, the appropriate classification is DIRS (Director's Dealing).
2008-01-22 English
NuSep Biannual Company Briefing 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a press release announcing NuSep Ltd's first biannual company briefing event, including details about the event date, location, and agenda. It contains no financial statements, regulatory filings, or detailed financial data. It is an announcement of an upcoming event rather than a report or detailed presentation. The document length is short (2710 characters), and it does not contain any financial results or management discussion. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Investor Presentation. It is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other specific categories.
2007-11-25 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.